UK MHRA grants authorisation for Moderna’s Covid-19 booster vaccine
The mRNA-1273.214 comprises mRNA-1273 and a vaccine candidate that acts on the SARS-CoV-2 virus’ BA.1 Omicron variant of concern.
Europe
Latest in
Europe
The potential of virtual reality-based therapy for serious mental disorders
Virtual reality (VR) technologies that can enhance recovery without anti-psychotics are an attractive option for treating mental illnesses.
By
Sartorius to acquire UK’s Albumedix for $501.5m
With the acquisition, Albumedix will become part of the Bioprocess Solutions Division of Sartorius.
EC grants approval for Merck-AstraZeneca’s Lynparza for breast cancer
The approval was based on the Phase III OlympiA clinical trial of Lynparza versus placebo.
EC’s HERA signs Covid-19 vaccine procurement deal with HIPRA
The HIPRA bivalent recombinant protein Covid-19 vaccine is presently under the EMA’s rolling review.
Sosei Heptares and AbbVie to develop therapies for neurological ailments
Sosei Heptares is entitled to receive up to $1.2bn in option, development and commercial milestone payments.
EMA task force begins review of Veru’s sabizabulin for Covid-19
The ETF will analyse all the available data, including findings from a trial in moderate-to-severe Covid-19 patients.
EC grants approval for AbbVie’s Rinvoq to treat ulcerative colitis in adults
The latest approval is based on findings from three randomised, multicentre, Phase III trials of Rinvoq.